首页 | 本学科首页   官方微博 | 高级检索  
检索        

氟尿嘧啶和奥沙利铂在胃癌中的体外化疗敏感性检测
引用本文:陈小东,赵平,丁志,周祥,肖硕萌,唐令超.氟尿嘧啶和奥沙利铂在胃癌中的体外化疗敏感性检测[J].四川肿瘤防治,2014(4):165-170.
作者姓名:陈小东  赵平  丁志  周祥  肖硕萌  唐令超
作者单位:四川省肿瘤医院·研究所 胃肠外科,成都610041
基金项目:四川省科技计划项目(No.2014FZ0089).
摘    要:目的:探讨氟尿嘧啶(5-FU)和奥沙利铂(OX)在胃癌中的体外化疗敏感性。方法:纳入病理确诊并自愿接受检测的胃癌患者,采用ATP肿瘤化疗敏感性检测法( ATP-TCA)检测新鲜手术标本对5-FU和OX的体外化疗敏感性。结果:纳入27例,男性21例、女性6例,中位年龄60.0岁,远侧部胃癌14例(51.9%),低分化及印戒细胞癌共20例(74.1%),TNM Ⅲ+Ⅳ期21例(77.8%)。 ATP-TCA检测显示5-FU+OX在各药物浓度的肿瘤生长抑制率均显著高于5-FU或OX(P〈0.05),5-FU+OX的抑制曲线下面积显著高于5-FU或OX(P〈0.05);而其化疗敏感指数、IC90和IC50显著低于5-FU或OX ( P〈0.05)。5-FU、OX和5-FU+OX的体外化疗敏感性依次为18.5%、14.8%和55.6%,5-FU+OX的敏感性显著高于5-FU或OX(5-FU+OX vs.5-FU:P=0.001和5-FU+OX vs. OX:P=0.003)。 Logistic回归分析显示5-FU的敏感性与临床病理特征无显著相关性,而OX和5-FU+OX的敏感性分别与Borrmann分型(OR=7.570,P=0.025)和肿瘤位置(OR=3.427,P=0.019)有显著相关性。结论:5-FU+OX在胃癌中显示出较高的体外化疗敏感性,但其与体内疗效的相关性有待进一步临床观察。

关 键 词:胃癌  三磷酸腺苷  化疗敏感性  氟尿嘧啶  奥沙利铂

In Vitro Chemosensitivity of Fluorouracil and Oxaliplatin in Gastric Cancer
Institution:Chen Xiao-dong, Zhao Ping, Ding Zhi, et al (Department of Gastrointestinal Surgery, Sichuan Cancer Hospital and Institute, Chengdu 610041, Sichuan, China)
Abstract:Objective: To investigate the in vitro chemosensitivity of fluorouracil (5-FU) and oxaliplatin (OX) in gastric cancer. Methods:Patients with histologically confirmed gastric cancer were enrolled for the study. All patients a-greed to the chemosensitivity test of their resected tumors and gave informed consent. Adenosine triphosphate tumor chemo-sensitivity assay ( ATP-TCA) was performed to determine the chemosensitivity of 5-FU and OX in resected gastric cancer specimens. Results:Twenty-seven patients with a median age of 60. 0 were enrolled, including 21 males and 6 females. The tumors were located in the lower part of the stomach in 14 cases, 20 cases were poorly differentiated or signet-ring cell carcinoma and 21 cases were in late TNM stage. ATP-TCA assay showed that the tumor growth inhibition rates of 5-FU+OX were significantly higher than those of 5-FU or OX at each test drug concentration ( P〈0. 05 ); correspondingly, the area under the curve of 5-FU+OX was significantly higher than those of 5-FU or OX (P〈0. 05), whereas their chemosen-sitivity index, IC90 and IC50 were significantly lower than those of 5-FU or OX (P〈0. 05). The chemosensitivity rates of 5-FU, OX and 5-FU+OX were 18. 5%, 14. 8% and 55. 6%, respectively; chemosensitivity of 5-FU+OX was signifi-cantly higher than that of 5-FU or OX (5-FU+OX vs. 5-FU:P=0. 001 and 5-FU+OX vs. OX:P=0. 003). Logistic re-gression analysis indicated that the chemosensitivity of 5-FU was not significantly correlated with any clinicopathological characteristics;however, the chemosensitivity of OX and 5-FU+OX was significantly correlated with Borrmann type ( OR=7. 570, P=0. 025) and tumor location (OR=3. 427, P=0. 019), respectively. Conclusion:5-FU+OX showed high in vitro chemosensitivity in gastric cancer, and may be worthy of further exploration to see its correlation with in vivo efficacy.
Keywords:Gastric Cancer  Adenosine Triphosphate  Chemosensitivity  Fluorouracil  Oxaliplatin
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号